The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033
Market Overview
The peptide-based metabolic disorders therapeutics market has seen significant growth in recent years.
- 2023 Market Size: $26.03 billion.
- 2024 Forecast: Expected to reach $29.89 billion.
- CAGR: 14.8% from 2023 to 2024.
Factors Driving Growth
- Prevalence of Metabolic Disorders: Increase in disorders like diabetes and obesity.
- Advancements in Peptide Synthesis: Improved technologies boosting drug development.
- Healthcare Expenditure: Rising global healthcare spending.
- Aging Population: Growing number of elderly patients requiring treatment.
- Biopharmaceutical Expansion: Industry growth leading to more peptide-based therapies.
- Regulatory Approvals: More therapies receiving green light from authorities.
- Personalized Medicine: Increased awareness and adoption.
View More On The Peptide Based Metabolic Disorders Therapeutics Market Report 2024 –
https://www.thebusinessresearchcompany.com/report/peptide-based-metabolic-disorders-therapeutics-global-market-report
Future Market Projections
- 2028 Market Size: Expected to grow to $52.16 billion.
- CAGR: 14.9% from 2024 to 2028.
Key Drivers for Future Growth
- Development of Novel Peptide Analogs: Introduction of new and effective treatments.
- R&D Investments: Increasing investments in research for metabolic disorders.
- Precision Medicine: Growing adoption of targeted therapies.
- Emerging Markets: Expansion in regions like Asia-Pacific.
- Collaborations in Drug Development: Partnerships accelerating innovation.
- Advancements in Delivery Technologies: Enhanced drug delivery methods.
- Patient-Centric Therapies: Focus on improving patient experiences and outcomes.
Emerging Trends in the Market
- AI in Drug Discovery: Artificial intelligence accelerating research.
- Personalized Therapies: Tailored treatments becoming mainstream.
- CRISPR/Cas9 Utilization: Gene-editing technologies being integrated.
- Wearable Devices: Devices for continuous patient monitoring.
- Oral Peptide Formulations: Development of oral delivery options.
- Digital Therapeutics: Rise in digital tools for managing diseases.
- Biobanking: Expansion of biobanks for personalized treatment options.
Obesity’s Role in Market Expansion
- Obesity’s Impact: Rising obesity rates driving demand for peptide-based therapies.
- Contributing Factors:
- Sedentary lifestyles.
- Unhealthy diets.
- Genetic predisposition.
- Therapeutic Focus:
- Regulating metabolic functions.
- Improving insulin sensitivity.
- Controlling appetite.
Notable Companies in the Market
- Key Players:
- Pfizer Inc., Johnson & Johnson, Roche Holding AG.
- Merck & Co. Inc., AbbVie Inc., Sanofi SA.
- Bristol-Myers Squibb, AstraZeneca, Novartis AG.
- Takeda Pharmaceutical, GlaxoSmithKline, Boehringer Ingelheim.
- Eli Lilly, Amgen, Gilead Sciences, Novo Nordisk.
- Teva Pharmaceutical, Regeneron, Biogen, Vertex, Jazz Pharmaceuticals.
Innovation in Biosimilars
- Biosimilars in Focus:
- Companies developing peptide-based anti-diabetic biosimilars.
- Example: Glenmark Pharmaceuticals launched Lirafit, a biosimilar of Liraglutide, in January 2024.
- Benefits:
- Lowering glycemic levels.
- Promoting weight reduction.
- Enhancing cardiovascular safety.
Strategic Acquisitions
- Roche’s Acquisition of Carmot Therapeutics:
- Deal Value: $2.7 billion in December 2023.
- Acquisition Focus: Clinical-stage incretins like CT-388 for obesity treatment.
- Company Overview: Carmot Therapeutics specializes in peptide-based therapeutics for metabolic disorders.
Geographic Insights
- Largest Region: North America dominated the market in 2023.
- Fastest-Growing Region: Asia-Pacific expected to lead growth in the coming years.
The peptide-based metabolic disorders therapeutics market is poised for robust expansion, driven by innovation, strategic investments, and a growing need for effective treatments.
Request A Sample Of The Global Peptide Based Metabolic Disorders Therapeutics Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=16764&type=smp